• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双盲研究以探究预防头孢噻吩所致静脉炎的方法。

Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.

作者信息

Maddox R R, Rush D R, Rapp R P, Foster T S, Mazella V, McKean H E

出版信息

Am J Hosp Pharm. 1977 Jan;34(1):29-34.

PMID:831472
Abstract

Methods which might be useful in preventing cephalothin-induced phlebitis following intravenous administration of the buffered drug were investigated. One hundred and twenty adult orthopedic patients were assigned randomly to either a control group or one of five treatment groups. The treatment regimens studied were: addition of hydrocortisone phosphate 10 mg to each liter of intravenous fluid; addition of heparin 1,000 units to each liter of intravenous fluid; addition of heparin 500 units and hydrocortisone phosphate 1 mg to each liter of intravenous fluid; addition of heparin 1,000 units and hydrocortisone phosphate 10 mg to each liter of intravenous fluid; and filtration of intravenous solutions through a 0.22-mum inline filter. All patients in the study received intravenous buffered cephalothin at a dosage of 1 g every six hours for a minimum of 48 hours. Phlebitis was assessed every 12 hours according to predetermined criteria. Significant differences were found in the incidence of phlebitis at 48 hours between the control group and the last three study groups (see above). It is concluded that postinfusion phlebitis following cephalothin administration can be reduced by the concomitant addition of heparin and hydrocortisone to the intravenous solution or by the use of an inline 0.22-mum final filter.

摘要

研究了在静脉注射缓冲药物后预防头孢噻吩引起的静脉炎可能有用的方法。120名成年骨科患者被随机分为对照组或五个治疗组之一。所研究的治疗方案为:每升静脉输液中添加10毫克磷酸氢化可的松;每升静脉输液中添加1000单位肝素;每升静脉输液中添加500单位肝素和1毫克磷酸氢化可的松;每升静脉输液中添加1000单位肝素和10毫克磷酸氢化可的松;以及通过0.22微米在线过滤器过滤静脉溶液。研究中的所有患者均接受静脉注射缓冲头孢噻吩,剂量为每6小时1克,至少持续48小时。根据预定标准每12小时评估一次静脉炎。在对照组与最后三个研究组之间,48小时时静脉炎的发生率存在显著差异(见上文)。得出的结论是,在静脉溶液中同时添加肝素和氢化可的松或使用0.22微米在线终端过滤器可降低头孢噻吩给药后的输注后静脉炎。

相似文献

1
Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.双盲研究以探究预防头孢噻吩所致静脉炎的方法。
Am J Hosp Pharm. 1977 Jan;34(1):29-34.
2
Double-blind comparison of phlebitis associated with cefazolin and cephalothin.
Int J Clin Pharmacol Biopharm. 1976 Jul;14(1):75-7.
3
Phlebitis associated with the intravenous use of cephalothin and cephapirin.与静脉使用头孢噻吩和头孢匹林相关的静脉炎。
Am J Hosp Pharm. 1976 Jul;33(7):642-4.
4
Effect of inline filtration of intravenous infusions on the incidence of thrombophlebitis.
Am J Hosp Pharm. 1977 Oct;34(10):1068-70.
5
Filtration and infusion phlebitis: a double-blind prospective clinical study.过滤与输注性静脉炎:一项双盲前瞻性临床研究。
Am J Hosp Pharm. 1975 Oct;32(10):1001-7.
6
Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis.
Am J Hosp Pharm. 1976 Nov;33(11):1160-3.
7
Effect of inline filtration on postinfusion phlebitis.在线过滤对输液后静脉炎的影响。
Clin Pharm. 1983 Jan-Feb;2(1):58-61.
8
Effect of filtration on complications of postoperative intravenous therapy.
Am J Hosp Pharm. 1979 Oct;36(10):1355-6.
9
Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.一项关于过滤与输注性静脉炎的临床研究的颗粒物评估
Am J Hosp Pharm. 1976 Jun;33(6):543-6.
10
Effect of buffering on the incidence and severity of cephalothin-induced phlebitis.
Am J Hosp Pharm. 1974 Mar;31(3):266-8.

引用本文的文献

1
Clinically-indicated replacement versus routine replacement of peripheral venous catheters.外周静脉导管的临床指征性更换与常规更换
Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007798. doi: 10.1002/14651858.CD007798.pub5.
2
Peripheral Venous Catheter-Related Adverse Events: Evaluation from a Multicentre Epidemiological Study in France (the CATHEVAL Project).外周静脉导管相关不良事件:来自法国一项多中心流行病学研究(CATHEVAL项目)的评估
PLoS One. 2017 Jan 3;12(1):e0168637. doi: 10.1371/journal.pone.0168637. eCollection 2017.
3
Infusion phlebitis assessment measures: a systematic review.
静脉输液性静脉炎评估措施:一项系统评价
J Eval Clin Pract. 2014 Apr;20(2):191-202. doi: 10.1111/jep.12107. Epub 2014 Jan 8.
4
Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.肝素在外周静脉和动脉导管中的益处:随机对照试验的系统评价和荟萃分析
BMJ. 1998 Mar 28;316(7136):969-75. doi: 10.1136/bmj.316.7136.969.
5
Influence of fine-bore catheter length on infusion thrombophlebitis in peripheral intravenous nutrition: a randomised controlled trial.细孔导管长度对周围静脉营养中输注性血栓性静脉炎的影响:一项随机对照试验。
Ann R Coll Surg Engl. 1997 May;79(3):221-4.
6
Parenteral nutrition via peripheral veins: a feasibility study.经外周静脉肠外营养:一项可行性研究。
J R Soc Med. 1987 Jul;80(7):430-3. doi: 10.1177/014107688708000712.
7
Ampoules, infusions, and filters.安瓿、输液器和过滤器。
Br Med J (Clin Res Ed). 1986 Mar 15;292(6522):714-5. doi: 10.1136/bmj.292.6522.714.
8
Development of thrombophlebitis in peripheral veins with Vialon and PTFE-Teflon cannulas: a double-blind, randomised, controlled trial.使用维纶和聚四氟乙烯套管时外周静脉血栓性静脉炎的发生情况:一项双盲、随机、对照试验。
Ann R Coll Surg Engl. 1991 Sep;73(5):322-5.
9
Potential for extending survival of peripheral intravenous infusions.延长外周静脉输液存活时间的潜力。
BMJ. 1992 Mar 7;304(6827):619-24. doi: 10.1136/bmj.304.6827.619.